scholarly journals P20: Understanding the impact of a cure for hepatitis C from the patient perspective

2013 ◽  
Vol 20 ◽  
pp. 27-28 ◽  
Author(s):  
S Lane ◽  
S Cline ◽  
S Szabo ◽  
K Beusterien ◽  
E Hautamaki ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Patient Perspective ◽  
The Impact

Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C

2005 ◽  
Vol 42 (5) ◽  
pp. 639-645 ◽  
Author(s):  
María Buti ◽  
Ramón San Miguel ◽  
Max Brosa ◽  
Juan M. Cabasés ◽  
Montserrat Medina ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The Impact

scholarly journals Virological Factors Associated with Failure to the Latest Generation of Direct Acting Agents (DAA) and Re-Treatment Strategy: A Narrative Review

Viruses ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 432
Author(s):  
Lorenzo Onorato ◽  
Mariantonietta Pisaturo ◽  
Mario Starace ◽  
Carmine Minichini ◽  
Alessandra Di Fraia ◽  
...  
Keyword(s):  
Liver Disease ◽  
Hepatitis C ◽  
Antiviral Agents ◽  
Clinical Problem ◽  
Narrative Review ◽  
Factors Associated ◽  
Direct Acting Antiviral ◽  
Direct Acting ◽  
The Impact ◽  
Direct Acting Antiviral Agents

The availability of all oral direct acting antiviral agents (DAAs) has revolutionized the management of HCV infections in recent years, allowing to achieve a sustained virological response (SVR) in more than 95% of cases, irrespective of hepatitis C Virus (HCV) genotype or staging of liver disease. Although rare, the failure to the latest-generation regimens (grazoprevir/elbasvir, sofosbuvir/velpatasvir, pibrentasvir/glecaprevir) represents a serious clinical problem, since the data available in the literature on the virological characteristics and management of these patients are few. The aim of the present narrative review was to provide an overview of the impact of baseline RASs in patients treated with the latest-generation DAAs and to analyze the efficacy of the available retreatment strategies in those who have failed these regimens.

Overview of the Patient Perspective at OMERACT 10 — Conceptualizing Methods for Developing Patient-Reported Outcomes

2011 ◽  
Vol 38 (8) ◽  
pp. 1699-1701 ◽  
Author(s):  
JOHN R. KIRWAN ◽  
PETER S. TUGWELL
Keyword(s):  
Clinical Trials ◽  
Experimental Work ◽  
Patient Reported Outcomes ◽  
Patient Perspective ◽  
Methodological Issues ◽  
Instrument Selection ◽  
Patient Reported ◽  
The Impact ◽  
Choice Of Instruments ◽  
The Way

This overview draws out the main conclusions from the 4 workshops focused on incorporating the patient perspective into outcome assessment at the 10th Outcome Measures in Rheumatology (OMERACT 10) conference. They raised methodological issues about the choice of outcome domains to include in clinical trials, the development or choice of instruments to measure these domains, and the way these instruments might capture the impact of a disease and its treatment. The need to develop a more rigorous conceptual model of quantifying the way conditions affect health, and the need to ensure patients are directly involved in the decisions about domains and instruments, emerged clearly. The OMERACT participants voted to develop guidelines for domain and instrument selection, and conceptual and experimental work will be brought forward to revise and upgrade the OMERACT Filter.

scholarly journals The Impact of Illicit Drug Use on Spontaneous Hepatitis C Clearance: Experience from a Large Cohort Population Study

PLoS ONE ◽  
2011 ◽  
Vol 6 (8) ◽  
pp. e23830 ◽  
Author(s):  
Hossein Poustchi ◽  
Saeed Esmaili ◽  
Ashraf Mohamadkhani ◽  
Aghbibi Nikmahzar ◽  
Akram Pourshams ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Drug Use ◽  
Population Study ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Large Cohort ◽  
The Impact

The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source

2007 ◽  
Vol 14 (4) ◽  
pp. 255-259 ◽  
Author(s):  
C. Goulding ◽  
C. O'Brien ◽  
H. Egan ◽  
J. E. Hegarty ◽  
G. McDonald ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Single Source ◽  
Prothrombotic Risk Factors ◽  
The Impact

scholarly journals Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

2021 ◽  
Vol 10 ◽  
pp. 100129
Author(s):  
Nick Scott ◽  
Thin Mar Win ◽  
Tom Tidhar ◽  
Hla Htay ◽  
Bridget Draper ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Economic Benefits ◽  
The Impact ◽  
Impact Cost

A Comparison of Depression Screening Instruments in Hepatitis C and the Impact of Depression on Somatic Symptoms

2011 ◽  
Vol 52 (5) ◽  
pp. 433-440 ◽  
Author(s):  
Sanjeev Sockalingam ◽  
Diana Blank ◽  
Abdulqader Al Jarad ◽  
Fahad Alosaimi ◽  
Gideon Hirschfield ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Somatic Symptoms ◽  
Depression Screening ◽  
Screening Instruments ◽  
The Impact

scholarly journals The Impact of Human T-Cell Lymphotropic Virus I Infection on Clinical and Immunologic Outcomes in Patients Coinfected With HIV and Hepatitis C Virus

2011 ◽  
Vol 57 ◽  
pp. S202-S207 ◽  
Author(s):  
Fabianna Bahia ◽  
Vinicius Novais ◽  
Jennifer Evans ◽  
Chloe Le Marchand ◽  
Eduardo Netto ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
T Cell ◽  
Human T Cell ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document